rdf:type |
|
lifeskim:mentions |
umls-concept:C0003595,
umls-concept:C0007222,
umls-concept:C0017431,
umls-concept:C0019425,
umls-concept:C0020445,
umls-concept:C0332281,
umls-concept:C0681850,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2697811
|
pubmed:issue |
6
|
pubmed:dateCreated |
2003-6-10
|
pubmed:abstractText |
Familial hypercholesterolemia (FH) is a genetic disorder characterized by high low-density lipoprotein cholesterol levels and premature cardiovascular disease (CVD). There are important differences in the presence of CVD among heterozygous subjects with FH. Some of this variability can be explained by genetic factors, and the apolipoprotein (apo) E genotype has been proposed as a useful marker.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1097-6744
|
pubmed:author |
pubmed-author:AlonsoRR,
pubmed-author:CastilloSS,
pubmed-author:CenarroAA,
pubmed-author:CiveiraFF,
pubmed-author:García-AlvarezII,
pubmed-author:MozasPP,
pubmed-author:PECKH DHD,
pubmed-author:PocovíMM,
pubmed-author:PuzoJJ,
pubmed-author:ReyesGG,
pubmed-author:Spanish group FH,
pubmed-author:TejedorDD
|
pubmed:issnType |
Electronic
|
pubmed:volume |
145
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
999-1005
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
|
pubmed:year |
2003
|
pubmed:articleTitle |
Apolipoprotein E genotype is not associated with cardiovascular disease in heterozygous subjects with familial hypercholesterolemia.
|
pubmed:affiliation |
Departamento Bioquímica, Biología Molecular-Celular, Universidad de Zaragoza, Zaragoza, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|